RNSCLC-PRSP software to predict the prognostic risk and survival in patients with resected T1-3N0–2 M0 non-small cell lung cancer

被引:0
|
作者
Yunkui Zhang
YaoChen Li
Rongsheng Zhang
Yujie Zhang
Haitao Ma
机构
[1] The First Affiliated Hospital of Soochow University,Department of Thoracic Surgery
[2] Shanxi Tumor Hospital,Department of Thoracic Surgery
[3] Guangdong Provincial Key Laboratory on Breast Cancer Diagnosis and Treatment Research,The Central Laboratory of Cancer Hospital of Shantou University Medical College
来源
关键词
Resected non-small cell lung cancer; Prognostic risk prediction; Survival prediction; Prognostic index; Software;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] RNSCLC-PRSP software to predict the prognostic risk and survival in patients with resected T1-3N0-2M0 non-small cell lung cancer
    Zhang, Yunkui
    Li, YaoChen
    Zhang, Rongsheng
    Zhang, Yujie
    Ma, Haitao
    [J]. BIODATA MINING, 2019, 12 (01)
  • [2] Patterns of failure and overall survival in patients with completely resected T3 no M0 non-small cell lung cancer
    Gould, PM
    Bonner, JA
    Sawyer, TE
    Deschamps, C
    Lange, CM
    Li, HZ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (01): : 91 - 95
  • [3] Oncologic Outcomes of Patients with Resected T3N0M0 Non-small Cell Lung Cancer
    Marques, E.
    Kennedy, K.
    Nishimura, K.
    Giroux, D.
    Cilento, V.
    Fang, W.
    Ugalde, P.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S866 - S867
  • [4] Oncologic Outcomes of Patients With Resected T3N0M0 Non-small Cell Lung Cancer
    Marques, Edouard
    Kennedy, Kevin F.
    Giroux, Dorothy J.
    Cilento, Vanessa B.
    Nishimura, Katherine K.
    Fang, Wentao
    Figueroa, Paula Ugalde
    [J]. SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2023, 35 (04) : 796 - 804
  • [5] Hypofractionated Radiation Therapy for Central T1-3N0 Non-small Cell Lung Cancer
    Oh, D.
    Ahn, Y.
    Park, H.
    Lim, D.
    Pyo, H.
    Kim, B.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S585 - S585
  • [6] A Nomogram to Predict the Overall Survival of Patients With Resected T1-2N0-1M0 Non-Small Cell Lung Cancer and to Identify the Optimal Candidates for Adjuvant Chemotherapy in Stage IB or IIA Non-Small Cell Lung Cancer Patients
    Wang, Wei
    Zhou, Juying
    [J]. CANCER CONTROL, 2023, 30
  • [7] Lymph node type as a prognostic factor for survival in T2 N1 M0 non-small cell lung carcinoma
    vanVelzen, E
    Snijder, RJ
    delaRiviere, AB
    Elbers, HRJ
    vandenBosch, JMM
    [J]. ANNALS OF THORACIC SURGERY, 1997, 63 (05): : 1436 - 1440
  • [8] Prognostic Value of Lymphovascular Invasion and Its Effect on Patterns of Recurrence in T1-3N0 Non-Small Cell Lung Cancer
    Kim, Y. S.
    Hong, J. H.
    Sung, S. Y.
    Kwak, Y.
    Lee, S.
    Park, J. K.
    Kim, K. S.
    Lee, K. Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S832 - S832
  • [9] Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer (NSCLC)
    Tanaka, F
    Yanagihara, K
    Otake, Y
    Yamada, T
    Shoji, T
    Miyahara, R
    Inui, K
    Wada, H
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2001, 19 (05) : 555 - 561
  • [10] T2N1M0 non-small cell lung cancer:: Surgery and prognostic factors
    Padilla, J
    Calvo, V
    Peñalver, JC
    Jordá, C
    Escrivá, J
    Cerón, J
    Zarza, AG
    Pastor, J
    Blasco, E
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2005, 41 (08): : 430 - 433